Form 4 for INSP Inspire Medical Systems, Inc.
Accepted 2025-02-18 00:00:00 ET · period of report 2025-02-09 · accession 0001104659-25-014860 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-18 | 2025-02-13 | INSP | Ban Randy | See Remarks | S - Sale+OE | $183.50 | -25.6K | 7,259 | -78% | -$4.69M |
| D | 2025-02-18 | 2025-02-13 | INSP | Ban Randy | See Remarks | M - OptEx | $67.63 | +25.0K | 32.8K | +319% | +$1.69M |
| D | 2025-02-18 | 2025-02-13 | INSP | Ban Randy | See Remarks | A - Grant | $0.00 | +5,076 | 7,843 | +183% | $0 |
| D | 2025-02-18 | 2025-02-09 | INSP | Ban Randy | See Remarks | F - Tax | $182.15 | -314 | 2,767 | -10% | -$57.2K |
| D | 2025-02-18 | 2025-02-13 | INSP | Ban Randy | See Remarks | M - OptEx | $0.00 | -25.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-13 | S | D | 2,500 | $178.54 | 30,343 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.08 to $178.93. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2025-02-13 | M | A | 25,000 | $67.63 | 32,843 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-13 | A | A | 5,076 | $0.00 | 7,843 | D | — | — | (F3) Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 13, 2026. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. |
| 4 | Common | Common Stock | 2025-02-13 | S | D | 1,000 | $179.41 | 29,343 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $179.12 to $179.75. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 5 | Common | Common Stock | 2025-02-13 | S | D | 1,330 | $180.79 | 28,013 | D | — | — | (F7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $180.29 to $181.27. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 6 | Common | Common Stock | 2025-02-13 | S | D | 3,770 | $181.90 | 24,243 | D | — | — | (F8) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $181.30 to $182.26. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 7 | Common | Common Stock | 2025-02-13 | S | D | 3,242 | $182.90 | 21,001 | D | — | — | (F9) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.30 to $183.27. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 8 | Common | Common Stock | 2025-02-13 | S | D | 2,541 | $183.79 | 18,460 | D | — | — | (F10) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $183.31 to $184.30. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 9 | Common | Common Stock | 2025-02-13 | S | D | 3,452 | $184.81 | 15,008 | D | — | — | (F11) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $184.33 to $185.31. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 10 | Common | Common Stock | 2025-02-13 | S | D | 3,824 | $185.84 | 11,184 | D | — | — | (F12) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.35 to $186.32. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 11 | Common | Common Stock | 2025-02-13 | S | D | 3,341 | $186.96 | 7,843 | D | — | — | (F13) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.35 to $187.29. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 12 | Common | Common Stock | 2025-02-13 | S | D | 584 | $187.66 | 7,259 | D | — | — | |
| 13 | Common | Common Stock | 2025-02-09 | F | D | 314 | $182.15 | 2,767 | D | — | — | (F1) Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award. (F2) Includes 25 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan on December 31, 2024. |
| 14 | Derivative | Stock Option (Right to Buy) | 2025-02-13 | M | D | 25,000 | $0.00 | 0 | D | $67.63 · — to 2029-07-31 | 25,000 Common Stock | (F14) Fully vested and exercisable. |